Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2019
Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement.
СтатьяConsensus StatementНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rosen Ilene M, Aurora R Nisha, Kirsch Douglas B, Carden Kelly A, Malhotra Raman K, Ramar Kannan, Abbasi-Feinberg Fariha, Kristo David A, Martin Jennifer L, Olson Eric J, Rosen Carol L, Rowley James A, Shelgikar Anita V, American Academy of Sleep Medicine Board of Directors
Аннотация
There is a complex relationship among opioids, sleep and daytime function. Patients and medical providers should be aware that chronic opioid therapy can alter sleep architecture and sleep quality as well as contribute to daytime sleepiness. It is also important for medical providers to be cognizant of other adverse effects of chronic opioid use including the impact on respiratory function during sleep. Opioids are associated with several types of sleep-disordered breathing, including sleep-related hypoventilation, central sleep apnea (CSA), and obstructive sleep apnea (OSA). Appropriate screening, diagnostic testing, and treatment of opioid-associated sleep-disordered breathing can improve patients' health and quality of life. Collaboration among medical providers is encouraged to provide high quality, patient-centered care for people who are treated with chronic opioid therapy.